Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Daiichi and Fuji prepare new analgesics

May 6, 1997

AMPA/NMDA receptor antagonists from Rhone-Poulenc Rorer

May 6, 1997

Hyal's Oralease receives Emergency Drug Release status in Canada

May 5, 1997

Synthelabo develops alternative to AChE inhibitors for AD

May 5, 1997

Pierre Fabre prepares agents with antidopaminergic/antiserotonergic effects

May 5, 1997

Preclinical results for N-3389 in emesis

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Delta-opioid receptor ligands reported by SmithKline Beecham

May 5, 1997

CoCensys and Novartis end stroke compound collaboration

May 2, 1997

Neurobiological Technologies initiates second phase II memantine trial

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
In the clinic for July 21, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 4D, Actinogen, Belite, Harrow, Nuvation, Prolocor, Regenxbio, Samsung Bioepis.
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...